Prestige BioPharma Limited Korean Deposit Receipt Repr 1/5 Sh (950210) Revenue

― Followers

Prestige BioPharma Limited Korean Deposit Receipt Repr 1/5 Sh Revenue

Prestige BioPharma Limited Korean Deposit Receipt Repr 1/5 Sh had a revenue of 5.51B in the quarter ending Jun 30, 2025, with 958.60%. This bring the company's revenue in the last twelve months to 14.19B, Increased -12.49%. In the fiscal year ending Jun 30, 2025, Prestige BioPharma Limited Korean Deposit Receipt Repr 1/5 Sh had annual revenue of 14.31B with 1976.67% growth.

Revenue (ttm)

14.19B

Revenue Growth

75.77%

P/S Ratio

26.00

Revenue/Employee

₩264,997,056

Employees

Market Cap

₩372.00B

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Jun 30, 2025	14.31B	13.62B	+1,976.67%
Jun 30, 2023	689.08M	―	+∞%
Jun 30, 2022	―	-161.84M	-100.00%
Jun 30, 2022	161.84M	―	+∞%
Jun 30, 2021	―	―	―
Jun 30, 2020	―	-2.09B	-100.00%
Jun 30, 2019	2.09B	―	+∞%
Jun 30, 2018	―	―	―